NASDAQ: SLGL

Israel-based dermatology specialist Sol-Gel Technologies Ltd. (NASDAQ: SLGL) has announced the signing of a licensing agreement with Shenzhen Beimei Pharmaceutical Co., Ltd, a China-based partner. According to the agreement, BeiMei will receive commercialization rights for Twyneo (benzoyl peroxide and tretinoin) cream, a treatment for acne vulgaris, in China mainland, Hong…